Skip to main content
Log in

Reversible Gastric Restriction Implant: Safety and Efficacy in a Canine Model

  • Animal Research
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background

Gastric restrictive procedures are considered effective weight loss treatment for severe obesity. The aim of the study was to evaluate the efficacy and safety of a reversible implant that renders a partial restriction of stomach in a canine model.

Methods

The device was comprised of two longitudinal parallel non-compressive plates with two C-rings to create a small gastric pouch that opposed gastric distension. Three groups of non-obese mongrel dogs were included: group I (n = 6) underwent surgical implant for 6 weeks, group II (n = 6) underwent surgical implant for 6 weeks, followed by surgical removal of the implant and additional monitoring for 5 weeks, and group III (n = 5) served as sham-operated controls for groups I and II. Food intake and body weight were monitored, and the stomachs were examined histologically postmortem.

Results

The average food intake was significantly decreased by 38.2% in group I as compared to group III throughout the 6 weeks of surgical implant (P < 0.05). The implanted dogs showed a progressive weight loss as compared to sham, which reached 21% by the end of 6 weeks. In group II, after 5 weeks of implant removal, the body weights recovered to approximately 96% of baseline. Histological evidence of the implant site at the gastric walls revealed no significant structural changes, tissue ischemia, hemorrhage, or necrosis.

Conclusion

Our results validate the feasibility of a reversible gastric restriction implant in a non-obese canine model, with the potential for achieving significant weight loss within 6 weeks and with no injury to the gastric wall.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Silventoinen K, Sans S, Tolonen H, et al. Trends in obesity and energy supply in the WHO MONICA Project. Int J Obes Relat Metab Disord. 2004;28:710–8.

    Article  PubMed  CAS  Google Scholar 

  2. do Carmo I, dos Santos O, Camolas J, et al. Prevalence of obesity in Portugal. Obes Rev. 2006;7:233–7.

    Article  PubMed  Google Scholar 

  3. Iannelli A, Dainese R, Piche T, et al. Laparoscopic sleeve gastrectomy for morbid obesity. World J Gastroenterol. 2008;14:821–7.

    Article  PubMed  Google Scholar 

  4. Suzuki S, Ramos EJ, Goncalves CG, et al. Changes in GI hormones and their effect on gastric emptying and transit times after Roux-en-Y gastric bypass in rat model. Surgery. 2005;138:283–90.

    Article  PubMed  Google Scholar 

  5. Schneider BE, Mun EC. Surgical management of morbid obesity. Diab Care. 2005;28:475–80.

    Article  Google Scholar 

  6. Kushner R. Diets, drugs, exercise, and behavioral modification: where these work and where they do not. Surg Obes Relat Dis. 2005;1:120–2.

    Article  PubMed  Google Scholar 

  7. Martin LF, Tan TL, Horn JR, et al. Comparison of the costs associated with medical and surgical treatment of obesity. Surgery. 1995;118:599–606.

    Article  PubMed  CAS  Google Scholar 

  8. Inge TH, Krebs NF, Garcia VF, et al. Bariatric surgery for severely overweight adolescents: concerns and recommendations. Pediatrics. 2004;114:217–23.

    Article  PubMed  Google Scholar 

  9. Buchwald H, Cowan GSM, Pories WJ, editors. Surgical management of obesity. Pennsylvania: Saunders; 2007. p. 102–7.

    Google Scholar 

  10. Martin L, Tan T, Holmes P, et al. Can morbidly obese patients lose weight preoperatively? Am J Surg. 1995;169:245–53.

    Article  PubMed  CAS  Google Scholar 

  11. Maclean LD, Rhode BM, Sampalis J. Results of the surgical treatment of obesity. Am J Surg. 1993;165:155–9.

    Article  PubMed  CAS  Google Scholar 

  12. Mason EE. Morbid obesity: use of vertical banded gastroplasty. Surg Clin North Am. 1987;67:521–53.

    PubMed  CAS  Google Scholar 

  13. Rubin M, Yehoshua RT, Stein M, et al. Laparoscopic sleeve gastrectomy with minimal morbidity. Early results in 120 morbidly obese patients. Obes Surg. 2008;18:1567–70.

    Article  PubMed  Google Scholar 

  14. Silecchia G, Boru C, Pecchia A, et al. Effectiveness of laparoscopic sleeve gastrectomy (first stage of biliopancreatic diversion with duodenal switch) on co-morbidities in super-obese high-risk patients. Obes Surg. 2006;16:1138–44.

    Article  PubMed  Google Scholar 

  15. Buchwald H, Cowan GSM, Pories WJ, editors. Surgical management of obesity. Pennsylvania: Saunders; 2007. p. 267–77.

    Google Scholar 

  16. Naslund E, Backman L, Granstrom L, et al. Seven year results of vertical banded gastroplasty for morbid obesity. Eur J Surg. 1997;163:281–6.

    PubMed  CAS  Google Scholar 

  17. MacLean JD, Rhode BM, Forse RA. Late results of vertical banded gastroplasty for morbid and super obesity. Surgery. 1990;107:20–7.

    PubMed  CAS  Google Scholar 

  18. Gorecki P, Wise L, Brolin RE, et al. Complications of combined gastric restrictive and malabsorptive procedures: part 1. Curr Surg. 2003;60:138–44.

    Article  PubMed  Google Scholar 

  19. Morino F, Toppino M, Fronda G, et al. Weight loss and complications after vertical banded gastroplasty. Obes Surg. 1992;2:69–73.

    Article  PubMed  Google Scholar 

  20. Frezza EE, Reddy S, Gee LL, et al. Complications after sleeve gastrectomy for morbid obesity. Obes Surg. 2009;19:684–7.

    Article  PubMed  Google Scholar 

  21. Cottam D, Qureshi FG, Mattar SG, et al. Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg Endosc. 2006;20:859–63.

    Article  PubMed  CAS  Google Scholar 

  22. Guo X, Mattar S, Morales C, et al. Novel gastric sleeve magnetic implant: safety and efficacy in rats. Surg Obes Relat Dis. 2009;5:684–91.

    Article  PubMed  Google Scholar 

  23. Woodward B. Bariatric surgery options. Crit Care Nurs Q. 2003;26:89–100.

    PubMed  Google Scholar 

  24. Fisher BL, Little AG. Vertical silastic ring gastroplasty with Nissen fundoplication prevents reflux. Obes Surg. 1996;6:233–6.

    Article  PubMed  Google Scholar 

  25. Goergen M, Arapis K, Limgba A, et al. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic vertical banded gastroplasty: results of a 2-year follow-up study. Surg Endosc. 2007;21:659–64.

    Article  PubMed  CAS  Google Scholar 

  26. Brolin EB, Robertson LB, Kenler HA. Weight loss and dietary intake after vertical banded gastroplasty and Roux-en-Y gastric bypass. Ann Surg. 1994;220:782–90.

    Article  PubMed  CAS  Google Scholar 

  27. Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002;346:1623–30.

    Article  PubMed  Google Scholar 

  28. Langer FB, Reza Hoda MA, Bohdjalian A, et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg. 2005;15:1024–9.

    Article  PubMed  CAS  Google Scholar 

  29. Date Y, Kojima M, Hosoda H, et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology. 2000;141:4255–61.

    Article  PubMed  CAS  Google Scholar 

  30. Cohen R, Uzzan B, Bihan H, et al. Ghrelin levels and sleeve gastrectomy in super-super-obesity. Obes Surg. 2005;15:1501–2.

    Article  PubMed  Google Scholar 

  31. Foschi D, Corsi F, Rizzi A, et al. Vertical banded gastroplasty modifies plasma ghrelin secretion in obese patients. Obes Surg. 2005;15:1129–32.

    Article  PubMed  CAS  Google Scholar 

  32. Hanusch-Enserer U, Brabant G, Roden M. Ghrelin concentrations in morbidly obese patients after adjustable gastric banding. N Engl J Med. 2003;348:2159–60.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

This research was funded by GRest, Inc. and NIH SBIR Phase I grant R43DK083889. We wish to thank Mr. Mitchell L Keel and Mark Svendsen for excellent technical assistance.

Disclosures

GSK is founder of GRest, Inc. There are no other conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ghassan Kassab.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guo, X., Zheng, H., Mattar, S.G. et al. Reversible Gastric Restriction Implant: Safety and Efficacy in a Canine Model. OBES SURG 21, 1444–1450 (2011). https://doi.org/10.1007/s11695-010-0299-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-010-0299-4

Keywords

Navigation